[Immune-mediated inflammatory diseases in Germany : A cross-sectional analysis of comorbidities and pharmacotherapy].
Jan LeipeRenate SchmelzGabriela RiemekastenDiamant ThaçiJörg HenesKnut SchäkelAndreas PinterMichael SticherlingJoanna WegnerStefano FuscoMiriam LinkeValeria WeberKarina C ManzHolger BartzMarit RoeckenSandra SchmidtBimba F HoyerPublished in: Zeitschrift fur Rheumatologie (2023)
A considerable number of patients with IMIDs (16.9-27.5%) suffer from different diseases of the IMID group. They are frequently affected by accompanying illnesses and require interdisciplinary medical treatment.